...
首页> 外文期刊>Asian journal of andrology >High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
【24h】

High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection

机译:高体重指数在自由基前列腺切除术后预测多个前列腺癌淋巴结转移,延长盆腔淋巴结解剖

获取原文
           

摘要

Our aim is to evaluate the association between body mass index (BMI) and preoperative total testosterone (TT) levels with the risk of single and multiple metastatic lymph node invasion (LNI) in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Preoperative BMI, basal levels of TT, and prostate-specific antigen (PSA) were evaluated in 361 consecutive patients undergoing radical prostatectomy with extended pelvic lymph node dissection between 2014 and 2017. Patients were grouped into either nonmetastatic, one, or more than one metastatic lymph node invasion groups. The association among clinical factors and LNI was evaluated. LNI was detected in 52 (14.4%) patients: 28 (7.8%) cases had one metastatic node and 24 (6.6%) had more than one metastatic node. In the overall study population, BMI correlated inversely with TT (r = ?0.256; P < 0.0001). In patients without metastases, BMI inversely correlated with TT (r = ?0.282; P 28 kg m ?2 (P 28 kg m ?2 (P = 0.048). In our study, overweight and obese patients had a higher risk of harboring multiple prostate cancer lymph node metastases and lower TT levels when compared to patients with normal BMI.
机译:我们的目的是评估体重指数(BMI)和术前总睾酮(TT)水平之间的关联,其前列腺癌患者中的单一和多种转移性淋巴结侵袭(LNI)的风险是接受自由基前列腺切除术和延长的盆腔淋巴结解剖。在进行的361名患者中,在2014年和2017年间,在361名正在进行自由基前列腺切除术治疗的三种骨盆淋巴结解剖中,评估术前BMI,TT和前列腺特异性抗原(PSA)。患者将患者分为非负载性,一种或多于一种转移性淋巴结入侵群体。评估了临床因素和LNI之间的关联。在52例(14.4%)患者中检测到LNI:28例(7.8%)病例有一个转移节点,24个(6.6%)具有多于一个转移节点。在整体研究人群中,BMI与TT相关联(R = 0.256; P&#60 0.0001)。在没有转移的患者中,BMI与TT与TT相关(R = 0.282; p 28kgm≤2(p 28kgm≤2(p = 0.048)。在我们的研究中,超重和肥胖的患者患有多个患者的风险较高与常规BMI患者相比,前列腺癌淋巴结转移和降低TT水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号